A completely fractured zotarolimus‐eluting stent in an aortocoronary saphenous vein bypass graft

Venero, Carmelo V.; Aligeti, Venkata R.; Wortham, Dale C.

doi:10.1002/ccd.24312

Cited by 3 publications

(2 citation statements)

References 10 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“… 12 There are only a few case reports on ZES fracture in the literature. Venero et al 13 reported a ZES fracture in an aortocoronary saphenous vein bypass graft (SVG). Recently, Lee et al 14 described two cases of ZES fracture: one was detected with intravascular ultrasound (IVUS) and the other with conventional coronary angiography.…”

Section: Discussionmentioning

confidence: 99%

Zotarolimus-eluting stent fracture at initial implantation diagnosed with StentBoost

Özkan

Sinan

Gürmen

2016

SAGE Open Medical Case Reports

View full text Add to dashboard Cite

Stent fracture is a rare complication of drug-eluting stent implantation with a reported rate of 0.84%–3.2% in various clinical studies with first-generation drug-eluting stents and 29% in autopsy studies. Sirolimus-eluting stents with their closed cell design were reported to be more prone to fracture compared to paclitaxel-eluting stents. Other risk factors for stent fracture are multiple stenting, longer stent length, chronic renal failure, right coronary artery intervention, and a higher maximal inflation pressure. The role of angiography in diagnosing stent fracture is limited, a fact also questioning the reliability of angiographic data. Image enhancement techniques like StentBoost are widely available in new-generation angiography systems and are used to assess stent expansion, overlap size, or to localize the postdilation balloon. Here, we report a case of zotarolimus-eluting stent fracture at initial implantation diagnosed with StentBoost.

show abstract

Section: Discussionmentioning

confidence: 99%

Zotarolimus-eluting stent fracture at initial implantation diagnosed with StentBoost

Özkan

Sinan

Gürmen

2016

SAGE Open Medical Case Reports

View full text Add to dashboard Cite

show abstract

“…This further strengthens the argument that native complex coronary artery PCI should be the prioritized treatment for SVG failure. There have been some case reports suggesting that the excess DES restenosis rate in SVGs may be related to the excessive curvature and/or mobility of DES during cardiac contractions due to the distorted anatomy leading to stent fracture and failure of local drug delivery [ 57 , 58 , 59 ].…”

Section: Stent Choice In Svg Lesionsmentioning

confidence: 99%

Percutaneous Coronary Intervention of Native Artery Versus Bypass Graft in Patients with Prior Coronary Artery Bypass Graft Surgery

Farag¹,

Brilakis²,

Gasparini³

et al. 2022

Rev. Cardiovasc. Med.

View full text Add to dashboard Cite

Background: Percutaneous coronary intervention (PCI) is common in patients with prior coronary artery bypass graft surgery (CABG), however, there is limited data on the association between the PCI target-vessel and clinical outcomes. In this article, we provide a state-of-the-art overview of the contemporary management of patients with prior CABG and a clear indication for revascularization. Methods: We performed a structured literature search of PubMed and Cochrane Library databases from inception to March 2021. Relevant studies were extracted and synthesized for narrative review. Results: Twenty-six observational studies focusing on PCI of bypass graft versus native coronary artery lesions in 366,060 patients with prior CABG were included. The data from observational studies suggest that bypass graft PCI is associated with higher short-and long-term major adverse cardiac events compared to native coronary artery PCI. Conclusions: Whenever feasible, native coronary artery PCI should be the prioritized treatment for saphenous vein graft failure. Prospective randomized trials are needed to elucidate the optimal revascularization strategy for patients with prior CABG.

show abstract

“bad things happen in threes”: A story of saphenous vein graft failure, stent fracture, and stent loss

Singla

Brilakis

2012

Cathet Cardio Intervent

View full text Add to dashboard Cite

A completely fractured zotarolimus‐eluting stent in an aortocoronary saphenous vein bypass graft

Cited by 3 publications

References 10 publications

Zotarolimus-eluting stent fracture at initial implantation diagnosed with StentBoost

Zotarolimus-eluting stent fracture at initial implantation diagnosed with StentBoost

Percutaneous Coronary Intervention of Native Artery Versus Bypass Graft in Patients with Prior Coronary Artery Bypass Graft Surgery

“bad things happen in threes”: A story of saphenous vein graft failure, stent fracture, and stent loss

Contact Info

Product

Resources

About